Mark Jason Heath Ellison, Chief Development Officer: Opiant Pharmaceuticals OPNT Sell · Filed 23/01/31

Trade details

Type: Insider sale
Amount: $12,358.6
Shares · price: 610 sh · $20.26 a share
Held after: 18,751 sh
Stock: Opiant Pharmaceuticals OPNT
Person: Mark Jason Heath EllisonChief Development Officer
Trade date: 23/01/27
Filed: 23/01/31
Days to filing: 4 days

Sold 3.2% of holdings

Share of holding sold: 3.2%

Opiant Pharmaceuticals trades, last 26 weeks

What else happened in Opiant Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/28~23/02/26

Mark Jason Heath Ellison's recent trades

Mark Jason Heath EllisonChief Development Officer
SellOpiant Pharmaceuticals
Sell
Opiant Pharmaceuticals
OPNT
$9,474
469 sh
$9,474
Filed 23/01/09
Traded 23/01/09
Mark Jason Heath EllisonChief Development Officer
SellOpiant Pharmaceuticals
Sell
Opiant Pharmaceuticals
OPNT
$36.5K
1,806 sh
$36.5K
Filed 23/01/05
Traded 23/01/05

Mark Jason Heath Ellison, Chief Officer — sold $12.4K of Opiant Pharmaceuticals OPNT · 3.2% of holdings | Whalegun